Joong Bae Ahn


Ontology type: schema:Person     


Person Info

NAME

Joong Bae

SURNAME

Ahn

Publications in SciGraph latest 50 shown

  • 2021-10-12 Association between Fusobacterium nucleatum and patient prognosis in metastatic colon cancer in SCIENTIFIC REPORTS
  • 2021-04-07 A phase 1 dose-escalation and dose-expansion study to assess the safety and efficacy of CKD-516, a novel vascular disrupting agent, in combination with Irinotecan in patients with previously treated metastatic colorectal cancer in INVESTIGATIONAL NEW DRUGS
  • 2021-03-15 Phase 2 study of TAS-117, an allosteric akt inhibitor in advanced solid tumors harboring phosphatidylinositol 3-kinase/v-akt murine thymoma viral oncogene homolog gene mutations in INVESTIGATIONAL NEW DRUGS
  • 2020-12-03 Clinical features and KRAS mutation in colorectal cancer with bone metastasis in SCIENTIFIC REPORTS
  • 2020-04-07 Upfront radical surgery with total mesorectal excision followed by adjuvant FOLFOX chemotherapy for locally advanced rectal cancer (TME-FOLFOX): an open-label, multicenter, phase II randomized controlled trial in TRIALS
  • 2020-03-16 Clinical Significance of Preoperative Serum Carcinoembryonic Antigen Within the Normal Range in Colorectal Cancer Patients Undergoing Curative Resection in ANNALS OF SURGICAL ONCOLOGY
  • 2019-10-14 Objectively measured physical activity during chemotherapy in colon cancer patients in SUPPORTIVE CARE IN CANCER
  • 2018-06-09 The clinical implications of FDG-PET/CT differ according to histology in advanced gastric cancer in GASTRIC CANCER
  • 2018-06-01 T2-weighted signal intensity-selected volumetry for prediction of pathological complete response after preoperative chemoradiotherapy in locally advanced rectal cancer in EUROPEAN RADIOLOGY
  • 2018-03-15 Mapping of lateral pelvic lymph node recurrences in rectal cancer: a radiation oncologist’s perspective in JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
  • 2018-02-07 Prognostic implications of polycomb proteins ezh2, suz12, and eed1 and histone modification by H3K27me3 in sarcoma in BMC CANCER
  • 2017-09-02 Role of adjuvant chemotherapy in locally advanced rectal cancer with ypT0-3N0 after preoperative chemoradiation therapy and surgery in BMC CANCER
  • 2017-03-28 A phase 1, open label, dose escalation study to investigate the safety, tolerability, and pharmacokinetics of MG1102 (apolipoprotein(a) Kringle V) in patients with solid tumors in INVESTIGATIONAL NEW DRUGS
  • 2016-12-22 Study protocol of the Asian XELIRI ProjecT (AXEPT): a multinational, randomized, non-inferiority, phase III trial of second-line chemotherapy for metastatic colorectal cancer, comparing the efficacy and safety of XELIRI with or without bevacizumab versus FOLFIRI with or without bevacizumab in CANCER COMMUNICATIONS
  • 2016-10-13 A phase 3 trial evaluating panitumumab plus best supportive care vs best supportive care in chemorefractory wild-type KRAS or RAS metastatic colorectal cancer in BRITISH JOURNAL OF CANCER
  • 2016-10-03 Preoperative Serum Carcinoembryonic Antigen Level as a Prognostic Factor for Recurrence and Survival After Curative Resection Followed by Adjuvant Chemotherapy in Stage III Colon Cancer in ANNALS OF SURGICAL ONCOLOGY
  • 2016-07-22 High-risk clinicopathological features and their predictive significance in Korean patients with stage II colon cancer in JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
  • 2016-07-08 Prognostic implications of PD-L1 expression in patients with soft tissue sarcoma in BMC CANCER
  • 2016-05-26 Effects of microsatellite instability on recurrence patterns and outcomes in colorectal cancers in BRITISH JOURNAL OF CANCER
  • 2015-10-29 Benefit of Adjuvant Chemotherapy After Curative Resection of Lung Metastasis in Colorectal Cancer in ANNALS OF SURGICAL ONCOLOGY
  • 2015-06-28 Leiomyosarcoma: investigation of prognostic factors for risk-stratification model in INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY
  • 2015-01-15 Incorporation of Radiotherapy in the Multidisciplinary Treatment of Isolated Retroperitoneal Lymph Node Recurrence from Colorectal Cancer in ANNALS OF SURGICAL ONCOLOGY
  • 2014-08-09 Phase II gemcitabine and capecitabine combination therapy in recurrent or metastatic breast cancer patients pretreated with anthracycline and taxane in CANCER CHEMOTHERAPY AND PHARMACOLOGY
  • 2014-07-24 High KLF4 level in normal tissue predicts poor survival in colorectal cancer patients in WORLD JOURNAL OF SURGICAL ONCOLOGY
  • 2014-01-04 Predicting the pathologic response of locally advanced rectal cancer to neoadjuvant concurrent chemoradiation using enzyme-linked immunosorbent assays (ELISAs) for biomarkers in JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
  • 2013-11-08 A prospective, open-label, multicenter study of the clinical efficacy of extended-release hydromorphone in treating cancer pain inadequately controlled by other analgesics in SUPPORTIVE CARE IN CANCER
  • 2013-08-27 Efficacy and safety of everolimus in Korean patients with metastatic renal cell carcinoma in CANCER CHEMOTHERAPY AND PHARMACOLOGY
  • 2013-08-14 Prognostic Value of Mucinous Histology Depends on Microsatellite Instability Status in Patients with Stage III Colon Cancer Treated with Adjuvant FOLFOX Chemotherapy: A Retrospective Cohort Study in ANNALS OF SURGICAL ONCOLOGY
  • 2013-01-23 Randomized controlled trial of standardized education and telemonitoring for pain in outpatients with advanced solid tumors in SUPPORTIVE CARE IN CANCER
  • 2013-01-13 Pharmacogenetic analysis of adjuvant FOLFOX for Korean patients with colon cancer in CANCER CHEMOTHERAPY AND PHARMACOLOGY
  • 2012-10-12 Application of the Western-based adjuvant online model to Korean colon cancer patients; a single institution experience in BMC CANCER
  • 2012-07-30 Identification of a radiosensitivity signature using integrative metaanalysis of published microarray data for NCI-60 cancer cells in BMC GENOMICS
  • 2012-04-27 Circulating vascular endothelial growth factor receptor 2/pAkt-positive cells as a functional pharmacodynamic marker in metastatic colorectal cancers treated with antiangiogenic agent in INVESTIGATIONAL NEW DRUGS
  • 2012-02-16 VIPoma that arose from the rectum in a 65-year-old male patient in INTERNATIONAL JOURNAL OF COLORECTAL DISEASE
  • 2011-08-24 Upfront systemic chemotherapy and preoperative short-course radiotherapy with delayed surgery for locally advanced rectal cancer with distant metastases in RADIATION ONCOLOGY
  • 2011-05-24 Combining capecitabine, oxaliplatin, and gemcitabine (XELOXGEM) for colorectal carcinoma patients pretreated with irinotecan: a multicenter phase I/II trial in CANCER CHEMOTHERAPY AND PHARMACOLOGY
  • 2011-05-13 A phase I pharmacokinetic study of TSU-68 (a multiple tyrosine kinase inhibitor of VEGFR-2, FGF and PDFG) in combination with S-1 and oxaliplatin in metastatic colorectal cancer patients previously treated with chemotherapy in INVESTIGATIONAL NEW DRUGS
  • 2010-12-29 A Phase Ib pharmacokinetic study of the anti-angiogenic agent CKD-732 used in combination with capecitabine and oxaliplatin (XELOX) in metastatic colorectal cancer patients who progressed on irinotecan-based chemotherapy in INVESTIGATIONAL NEW DRUGS
  • 2010-08-31 The role of adjuvant pelvic radiotherapy in rectal cancer with synchronous liver metastasis: a retrospective study in RADIATION ONCOLOGY
  • 2010-06-11 Adjuvant radiotherapy following total mesorectal excision for stage IIA rectal cancer: is it beneficial? in INTERNATIONAL JOURNAL OF COLORECTAL DISEASE
  • 2010-05-23 Economic and patient-reported outcomes of outpatient home-based versus inpatient hospital-based chemotherapy for patients with colorectal cancer in SUPPORTIVE CARE IN CANCER
  • 2010-05-14 Brain metastases from colorectal carcinoma: prognostic factors and outcome in JOURNAL OF NEURO-ONCOLOGY
  • 2010-03-21 Phase II trial of S-1 monotherapy in elderly or frail patients with metastatic colorectal cancer in INVESTIGATIONAL NEW DRUGS
  • 2009-07-08 A phase I pharmacokinetic and pharmacodynamic study of CKD-732, an antiangiogenic agent, in patients with refractory solid cancer in INVESTIGATIONAL NEW DRUGS
  • 2009-02-18 Oncologic Outcomes After Radical Surgery Following Preoperative Chemoradiotherapy for Locally Advanced Lower Rectal Cancer: Abdominoperineal Resection Versus Sphincter-Preserving Procedure in ANNALS OF SURGICAL ONCOLOGY
  • 2009-01-24 Simvastatin plus irinotecan, 5-fluorouracil, and leucovorin (FOLFIRI) as first-line chemotherapy in metastatic colorectal patients: a multicenter phase II study in CANCER CHEMOTHERAPY AND PHARMACOLOGY
  • 2008-08-20 Postoperative adjuvant chemotherapy of gastric cancer: scrutiny into the clinical evidence based on quality assessment of medical literature of randomized controlled trials in CANCER CHEMOTHERAPY AND PHARMACOLOGY
  • 2008-01-15 Chemoradiotherapy with or without consolidation chemotherapy using cisplatin and 5-fluorouracil in anal squamous cell carcinoma: long-term results in 31 patients in BMC CANCER
  • 2007-11-20 Robotic total mesorectal excision for rectal cancer using four robotic arms in SURGICAL ENDOSCOPY
  • 2007-07-24 A phase II study of S-1 monotherapy administered for 2 weeks of a 3-week cycle in advanced gastric cancer patients with poor performance status in BRITISH JOURNAL OF CANCER
  • JSON-LD is the canonical representation for SciGraph data.

    TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

    [
      {
        "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
        "affiliation": [
          {
            "affiliation": {
              "id": "http://www.grid.ac/institutes/grid.15444.30", 
              "type": "Organization"
            }, 
            "isCurrent": true, 
            "type": "OrganizationRole"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.413046.4", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.410886.3", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.413967.e", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.264381.a", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.411945.c", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.419828.e", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.31501.36", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.240145.6", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.412091.f", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.411653.4", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.415562.1", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.410914.9", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.412480.b", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.412484.f", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.411134.2", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.256753.0", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.414964.a", 
            "type": "Organization"
          }
        ], 
        "familyName": "Ahn", 
        "givenName": "Joong Bae", 
        "id": "sg:person.010673374672.49", 
        "identifier": [
          {
            "name": "orcid_id", 
            "type": "PropertyValue", 
            "value": "0000-0001-6787-1503"
          }
        ], 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.010673374672.49", 
          "https://orcid.org/0000-0001-6787-1503"
        ], 
        "sdDataset": "persons", 
        "sdDatePublished": "2021-12-01T20:42", 
        "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
        "sdPublisher": {
          "name": "Springer Nature - SN SciGraph project", 
          "type": "Organization"
        }, 
        "sdSource": "s3://com-springernature-scigraph/baseset/20211201/entities/gbq_results/person/person_839.jsonl", 
        "type": "Person"
      }
    ]
     

    Download the RDF metadata as:  json-ld nt turtle xml License info

    HOW TO GET THIS DATA PROGRAMMATICALLY:

    JSON-LD is a popular format for linked data which is fully compatible with JSON.

    curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/person.010673374672.49'

    N-Triples is a line-based linked data format ideal for batch operations.

    curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/person.010673374672.49'

    Turtle is a human-readable linked data format.

    curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/person.010673374672.49'

    RDF/XML is a standard XML format for linked data.

    curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/person.010673374672.49'


     

    This table displays all metadata directly associated to this object as RDF triples.

    55 TRIPLES      11 PREDICATES      30 URIs      8 LITERALS      3 BLANK NODES

    Subject Predicate Object
    1 sg:person.010673374672.49 schema:affiliation N40e777e616bc46a8a0429c73cb6c788f
    2 grid-institutes:grid.240145.6
    3 grid-institutes:grid.256753.0
    4 grid-institutes:grid.264381.a
    5 grid-institutes:grid.31501.36
    6 grid-institutes:grid.410886.3
    7 grid-institutes:grid.410914.9
    8 grid-institutes:grid.411134.2
    9 grid-institutes:grid.411653.4
    10 grid-institutes:grid.411945.c
    11 grid-institutes:grid.412091.f
    12 grid-institutes:grid.412480.b
    13 grid-institutes:grid.412484.f
    14 grid-institutes:grid.413046.4
    15 grid-institutes:grid.413967.e
    16 grid-institutes:grid.414964.a
    17 grid-institutes:grid.415562.1
    18 grid-institutes:grid.419828.e
    19 schema:familyName Ahn
    20 schema:givenName Joong Bae
    21 schema:identifier Nec5d6aaa83e742448130e3aef8dcb5b7
    22 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.010673374672.49
    23 https://orcid.org/0000-0001-6787-1503
    24 schema:sdDatePublished 2021-12-01T20:42
    25 schema:sdLicense https://scigraph.springernature.com/explorer/license/
    26 schema:sdPublisher Nf3697c8e13ef4cc7bc2b795b03a57df6
    27 sgo:license sg:explorer/license/
    28 sgo:sdDataset persons
    29 rdf:type schema:Person
    30 N40e777e616bc46a8a0429c73cb6c788f schema:affiliation grid-institutes:grid.15444.30
    31 sgo:isCurrent true
    32 rdf:type schema:OrganizationRole
    33 Nec5d6aaa83e742448130e3aef8dcb5b7 schema:name orcid_id
    34 schema:value 0000-0001-6787-1503
    35 rdf:type schema:PropertyValue
    36 Nf3697c8e13ef4cc7bc2b795b03a57df6 schema:name Springer Nature - SN SciGraph project
    37 rdf:type schema:Organization
    38 grid-institutes:grid.15444.30 schema:Organization
    39 grid-institutes:grid.240145.6 schema:Organization
    40 grid-institutes:grid.256753.0 schema:Organization
    41 grid-institutes:grid.264381.a schema:Organization
    42 grid-institutes:grid.31501.36 schema:Organization
    43 grid-institutes:grid.410886.3 schema:Organization
    44 grid-institutes:grid.410914.9 schema:Organization
    45 grid-institutes:grid.411134.2 schema:Organization
    46 grid-institutes:grid.411653.4 schema:Organization
    47 grid-institutes:grid.411945.c schema:Organization
    48 grid-institutes:grid.412091.f schema:Organization
    49 grid-institutes:grid.412480.b schema:Organization
    50 grid-institutes:grid.412484.f schema:Organization
    51 grid-institutes:grid.413046.4 schema:Organization
    52 grid-institutes:grid.413967.e schema:Organization
    53 grid-institutes:grid.414964.a schema:Organization
    54 grid-institutes:grid.415562.1 schema:Organization
    55 grid-institutes:grid.419828.e schema:Organization
     




    Preview window. Press ESC to close (or click here)


    ...